Trial
NCT03943407
Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch
UnknownWITHDRAWNEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Aalborg University
Collaborators
—
Condition
Itch
Intervention
Zyclara 3.75 % Topical Cream
Why stopped
The Imiquimod 3.75% was ineffective
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-22